Amphix Bio is a biotechnology company developing a new class of peptide therapeutics for neurological injuries, neurodegenerative diseases, and musculoskeletal disorders. The company’s Supramolecular Therapeutic Peptide (STP) platform assembles nanostructures that activate cell receptors and combines peptide modifications with a proprietary sequence library to optimize therapeutic properties.
Leadership & Board
Current Number of Employees9
Current LinkedIn Followers692
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$13M
Total Amount Raised$13M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$13M
Latest Funding Amount$13M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Amphix Bio had 9 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
9Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Amphix Bio had 692 followers as of September 14, 2026. The number of followers increased by 7 (1.02%) week-over-week.
692Latest Followers Count
7(1.02%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 18, 2025
Seed Round
$12.50M
―
Similar Companies
A snapshot of private companies similar to Amphix Bio, helping you discover and navigate related company profiles.